mg132aproteasomeinhibitorenhancesldluptakeinhepg2cellsinvitrobyregulatingldlrandpcsk9expression
文献类型：期刊论文
| 作者 | Yan Hong; Ma Yanling; Gui Yuzhou; Wang Shumei; Wang Xinbo; Gao Fei; Wang Yiping
|
| 刊名 | actapharmacologicasinica
 |
| 出版日期 | 2014 |
| 卷号 | 35期号:8页码:994 |
| 关键词 | PROTEIN-KINASE-C SUBTILISIN/KEXIN TYPE 9 RECEPTOR CHOLESTEROL PATHWAY ELEMENT GENE TRANSCRIPTION EPSILON TARGET cholesterol homeostasis LDLR MG132 proteasome inhibition PKC PCSK9 pravastatin HepG2 cells |
| ISSN号 | 1671-4083 |
| DOI | 10.1038/aps.2014.52 |
| 英文摘要 | Aim: Expression of liver low-density lipoprotein receptor (LDLR), a determinant regulator in cholesterol homeostasis, is tightly controlled at multiple levels. The aim of this study was to examine whether proteasome inhibition could affect LDLR expression and LDL uptake in liver cells in vitro. |
| 语种 | 英语 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/284839]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | 中国科学院上海药物研究所 |
| 推荐引用方式 GB/T 7714 | Yan Hong,Ma Yanling,Gui Yuzhou,et al. mg132aproteasomeinhibitorenhancesldluptakeinhepg2cellsinvitrobyregulatingldlrandpcsk9expression[J]. actapharmacologicasinica,2014,35(8):994. |
| APA | Yan Hong.,Ma Yanling.,Gui Yuzhou.,Wang Shumei.,Wang Xinbo.,...&Wang Yiping.(2014).mg132aproteasomeinhibitorenhancesldluptakeinhepg2cellsinvitrobyregulatingldlrandpcsk9expression.actapharmacologicasinica,35(8),994. |
| MLA | Yan Hong,et al."mg132aproteasomeinhibitorenhancesldluptakeinhepg2cellsinvitrobyregulatingldlrandpcsk9expression".actapharmacologicasinica 35.8(2014):994. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。